Clinical trials sponsored by Gustave Roussy, Cancer Campus, Grand Paris

Phase breakdown

Conditions studied

Recruiting trials led by Gustave Roussy, Cancer Campus, Grand Paris

• A Study to Determine the Efficacy of a Digital Self-management Support Tool to Improve the Quality of Life During Adjuvant HOrmonal Therapy for Patients With Early Breast Cancer
  NCT06781996 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Study to Explore Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of Novel Therapeutics in Patients With Early Relapsed Metastatic Triple-negative Breast Cancer
  NCT06508216 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Cohort Evaluation of Body Fluids Early Detection of Cancer in High-risk Individuals
  NCT06907095 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Dose-Expansion Modular Study To Explore the Safety, Tolerability, and Anti-tumor Activity of HER3- DXd Monotherapy and Combinations in Patients With Inoperable Advanced Breast Cancer (ABC) After Progression on T-DXd
  NCT06298084 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• First-line Immunotherapy-based Standard of Care and Local Ablative Treatments for Oligometastatic Non-small Cell Lung Cancer Patients.
  NCT06840782 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of Cancer
  NCT07436312 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Maintenance Pembrolizumab at Usual or Low doSE in Non-squamous Lung Cancer: a Non-inferiority Study
  NCT05692999 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 37 locations
• Patritumab Deruxtecan (U3-1402) in Unresectable Locally Advanced or Metastatic Breast Cancer
  NCT04965766 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 11 locations
• Study Investigating ASP3082 in Patients With Metastatic/Locally Advanced Non-small-cell Lung Cancer (NSCLC) and Pancreatic Ductal Adenocarcinoma (PDAC), With Biomarker Analysis to Characterize Response/Resistance
  NCT07483983 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• tislelizUMaB in canceR Patients With molEcuLar residuaL Disease
  NCT06332274 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is Gustave Roussy, Cancer Campus, Grand Paris recruiting for?

Gustave Roussy, Cancer Campus, Grand Paris is the lead sponsor of 10 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.